How we connected at Melanoma March Virtual 2020
21 April 2020
We could not have asked for a better start to Melanoma March 2020 with superb events in Rockhampton and Sunshine Coast on Sunday 1 March. The following weekend a beautiful twilight gathering was held in Devonport on Saturday evening and then on Sunday inspiring events took place on the Central Coast and in Western Sydney, where participants demonstrated yet again that a bit of rain would not dampen the community spirit of Melanoma March.
After such a wonderful start it was then so disappointing when we made the decision to cancel our remaining 19 physical events, due to the escalating impact of COVID-19. We know what Melanoma March means to our community, so instead we created Melanoma March Virtual so that everyone across Australia could still come together (even if in a different way), as we have done at Melanoma March events for the last 9 years. We wanted people to still be able to honour loved ones and support each other.
It was so heart-warming to see how everyone embraced Melanoma March Virtual with enthusiasm. The creative ways in which people took steps whilst still social distancing was inspiring! Activities included bushwalking, bike-riding, backyard soccer, dog-walking, dancing, gardening, scooter-riding, stepping, horse-riding and even a morning tea party! Thank you so much to everyone who shared their pictures, videos and stories, and thank you to everyone who supported by donating over $310,000 to melanoma research. We hope, like us, everyone could feel the connection and support.
Watch the Event Welcome video below and see more of the activities on our Melanoma March Facebook or Instagram page.
Melanoma March 2020 Principal Partner is Ricky, Australia’s leading supplier of technical textiles and sun control fabrics.
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.
Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here.
Meet our latest Surgical Oncology Fellow, Eva Nagy, to find out more about life as a surgical oncologist, why she came to MIA and what she hopes to achieve.
Melanoma research at ASCO this year focussed on the more precise use of current treatments to ensure optimal treatment for each patient.
MIA recently demonstrated that reflectance confocal microscopy is a useful tool in the clinic to diagnose suspicious-looking lesions in the mouth.
New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.
Researchers from MIA will present their latest research findings to the world’s largest oncology conference in early June.
Australian researchers pioneer life-extending treatment for advanced melanoma patients with brain tumours
Australian researchers are the first to demonstrate that patients with advanced melanoma which has spread to the brain can have increased life expectancy and possibly even beat the disease.
Melanoma March 2017 - that's a wrap! Thank you to everyone that helped make it happen.
Thank you so much to all those who contributed in a variety of ways to Melanoma March 2017 in 17 different locations and more around the country! You have contributed to getting the Big Data for Melanoma national Research Project happening!
By looking at the ‘dark matter’ of the genome, new research has found that genetic changes in acral and mucosal melanoma are completely different to mutations found in skin melanoma.
‘Slip, slop, slap’ is synonymous with being Australian and playing it safe in the sun. These sun smart rules reduce our chances of getting melanoma of the skin. However, new research tells a different story for those affected by rarer forms of melanoma.
Using MIA's patient database, researchers have developed conditional survival estimates for Stage III melanoma patients to more accurately predict survival outcomes.
MIA is proud to be celebrating an important milestone – the 60th anniversary of melanoma research and Australian-led global efforts to find a cure.
Research achievements by MIA were celebrated at the annual Sydney Medical School recently.
In this Global Research Report we showcase advances in medical oncology, reveal unexpected pathology in acral and skin melanoma, and uncover biomarkers and new gene targets for melanoma.